Company Filing History:
1 out of 5,081 
1 out of 67 
1 out of 279 
Years Active: 2013
Title: Oumeya Adjali: Innovator in Immunodeficiency Treatment
Introduction
Oumeya Adjali is a notable inventor based in Montpellier, France. He has made significant contributions to the field of immunology, particularly in the treatment of immunodeficiencies. His innovative approach utilizes advanced techniques to enhance immune responses.
Latest Patents
Oumeya Adjali holds a patent for "Treating immunodeficiencies by intrathymic injection of nucleotide sequences." This invention involves the use of viral vectors that can stably integrate into the genome of thymic stromal cells or intrathymic lymphocytes. The patent aims to manufacture a medicine intended for intrathymic administration, focusing on the prevention or treatment of genetic and acquired immunodeficiencies. It also addresses the induction of immune tolerance to self or non-self gene products, cells, or tissues, and the prevention or treatment of autoimmune diseases. He has 1 patent to his name.
Career Highlights
Oumeya Adjali has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and Université Pierre et Marie Curie. His work in these organizations has allowed him to advance his research and contribute to significant scientific discoveries.
Collaborations
Oumeya has collaborated with notable colleagues, including Naomi Sitbon and David Klatzmann. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Oumeya Adjali's work in the field of immunology exemplifies the importance of innovation in medical science. His patent for treating immunodeficiencies showcases his commitment to improving health outcomes through advanced research.